Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Equity (2016 - 2025)

Historic Return on Equity for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to 0.2%.

  • Haemonetics' Return on Equity rose 500.0% to 0.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.2%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.19% for FY2025, which is 600.0% up from last year.
  • Latest data reveals that Haemonetics reported Return on Equity of 0.2% as of Q4 2025, which was up 500.0% from 0.19% recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Return on Equity ranged from a high of 0.2% in Q4 2025 and a low of 0.03% during Q1 2022
  • Over the past 5 years, Haemonetics' median Return on Equity value was 0.13% (recorded in 2022), while the average stood at 0.13%.
  • Per our database at Business Quant, Haemonetics' Return on Equity crashed by -1200bps in 2021 and then skyrocketed by 1000bps in 2022.
  • Over the past 5 years, Haemonetics' Return on Equity (Quarter) stood at 0.05% in 2021, then surged by 180bps to 0.13% in 2022, then grew by 8bps to 0.14% in 2023, then rose by 6bps to 0.15% in 2024, then skyrocketed by 37bps to 0.2% in 2025.
  • Its Return on Equity was 0.2% in Q4 2025, compared to 0.19% in Q3 2025 and 0.19% in Q2 2025.